MetLife (NYSE:MET) continues to net positive predictions with a new price target of $86.00 set by Keefe, Bruyette & Woods. The insurance company is largely viewed as an attractive stock, particularly due to its strong performance in the S&P 500 market. A share buyback plan has been initiated by the MetLife board of directors, and the decision has been made to increase its dividend to $0.545. Q1 2024 earnings reports are in, showing that adjusted EPS beat estimates and net income surged. The company's stock has seen a significant growth of 11.4% over three months.
Metlife MET News Analytics from Thu, 03 Aug 2023 07:00:00 GMT to Thu, 09 May 2024 13:00:12 GMT -
Rating 8
- Innovation 2
- Information 8
- Rumor -6
